Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INNO2VATE Conversion
2016-001360-11Phase 3Completed
- Sponsor
- Akebia Therapeutics
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vadadustat in Uraemic Anaemia (2 arms), sponsored by Akebia Therapeutics. Primary endpoint: Mean change in hemoglobin between baseline and the primary evaluation period. Started Oct 2016; status: completed.
02
Drugs
vadadustat
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2016-001360-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001360-11.